Scott Edmondson Email

Sr. VP and Head Chemistry . Nimbus Therapeutics

Current Roles

Employees:
122
Revenue:
$18.9M
About
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA). With its breakthrough computational chemistry platform, enabled through its privileged partnership with co-founder, Schrödinger, Inc., Nimbus is pioneering the application of computational chemistry to design treatments for substantial and underserved human diseases. The company?s focus on metabolic diseases, cancer and immune-inflammatory disorders reflects the mechanistic relationship between these disorders, and Nimbus? ability to rapidly tackle well validated targets as well as those that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry, resulting in medicines with high potency, selectivity and other desirable drug-like properties.
Nimbus Therapeutics Address
22 Boston Wharf Road
Cambridge, MA
United States

Past Companies

NSr. Vice President and Head of Chemistry
AstraZenecaDirector & Boston Head of Oncology Chemistry
MerckDirector, Discovery Chemistry

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.